Neuropeptide interactions and REM sleep: A role for Urotensin II?
Authors:
- Luis de LeceaLLLuis de Lecea
- Patrice BourginPBPatrice Bourgin
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Immunocytochemical Distribution of VIP and PACAP in the Rat Brain StemAnnals of the New York Academy of Sciences, 2006
- Hypocretin (Orexin) Receptor Subtypes Differentially Enhance Acetylcholine Release and Activate G Protein Subtypes in Rat Pontine Reticular FormationThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Orexin A in the VTA Is Critical for the Induction of Synaptic Plasticity and Behavioral Sensitization to CocaineNeuron, 2006
- Pharmacological characterization of SB‐710411 (Cpa‐c[D‐Cys‐Pal‐D‐Trp‐Lys‐Val‐Cys]‐Cpa‐amide), a novel peptidic urotensin‐II receptor antagonistBritish Journal of Pharmacology, 2002
- Urotensin II evokes potent vasoconstriction in humans in vivoBritish Journal of Pharmacology, 2002
- Muscarinic and PACAP receptor interactions at pontine level in the rat: significance for REM sleep regulationEuropean Journal of Neuroscience, 2000
- Long‐term enhancement of REM sleep by the pituitary adenylyl cyclase‐activating polypeptide (PACAP) in the pontine reticular formation of the ratEuropean Journal of Neuroscience, 1999
- Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14Nature, 1999
- Rapid eye movement sleep induction by vasoactive intestinal peptide infused into the oral pontine tegmentum of the rat may involve muscarinic receptorsNeuroscience, 1999
- The carbachol-induced enhancement of desynchronized sleep signs is dose dependent and antagonized by centrally administered atropineNeuropsychopharmacology, 1989